Geode Capital Management’s Immunovant IMVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$29.2M Buy
2025
Q1
$28.6M Buy
2024
Q4
$37.5M Buy
2024
Q3
$43.1M Buy
2024
Q2
$37.3M Buy
2024
Q1
$42.6M Buy
2023
Q4
$53.6M Buy
2023
Q3
$43.9M Sell
2023
Q2
$22.2M Buy
2023
Q1
$16.3M Buy
2022
Q4
$17.8M Buy
2022
Q3
$4.54M Buy
2022
Q2
$3.1M Buy
2022
Q1
$4.35M Sell
2021
Q4
$6.99M Sell
2021
Q3
$7.44M Buy
2021
Q2
$8.95M Buy
2021
Q1
$12.8M Buy
2020
Q4
$34.8M Buy
2020
Q3
$19.7M Buy
2020
Q2
$8.8M Buy
2020
Q1
$298K Buy